# Nuclide record falcon (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/falcon/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "falcon", "NCT02578940" ;
  schema:name "FALCON"@en ;
  schema:alternateName "18F-fluciclovine biochemical recurrence management trial"@en ;
  schema:description "A PET scan using the tracer fluciclovine (brand Axumin) was tested in UK men whose prostate cancer PSA had risen again, to see how often the scan changed the treatment doctors planned to give."@en ;
  schema:url <https://nuclide.cc/trials/falcon/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/32068113/>, <https://clinicaltrials.gov/study/NCT02578940>, <https://www.blueearthdiagnostics.com/hubfs/PR063.pdf> ;
  nuclide:status "completed" ;
  nuclide:tag "diagnostic trial", "prostate cancer", "biochemical recurrence", "management impact" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/drugs/fluciclovine-f18/>, <https://nuclide.cc/indications/prostate-bcr/>, <https://nuclide.cc/companies/blue-earth-diagnostics/>, <https://nuclide.cc/isotopes/f-18/> .